H. Shapiro

发表

Developmental expression of bone sialoprotein mRNA in rat mineralized connective tissues

J. Sodek, Jinkun Chen, J. Chen, 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Controlled comparison of gentamicin and tobramycin nephrotoxicity.

G. Matzke, H. Shapiro, R. Lucarotti, 1983, American journal of nephrology.

Characterization of porcine bone sialoprotein: primary structure and cellular expression.

Qi Zhang, J. Wrana, J. Sodek, 1993, Matrix.

Localization of bone sialoprotein (BSP) expression to sites of mineralized tissue formation in fetal rat tissues by in situ hybridization.

J. Wrana, J. Heersche, J. Sodek, 1991, Matrix.

Hypercalcaemia in acute renal failure of acute alcoholic rhabdomyolysis.

C. Hawker, T. Ing, H. Shapiro, 1972, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Characterization of the human bone sialoprotein (BSP) gene and its promoter sequence.

J. Wrana, J. Li, J. Sodek, 1994, Matrix biology : journal of the International Society for Matrix Biology.

Mesangiolysis: an important glomerular lesion in thrombotic microangiopathy.

Y. Koitabashi, H. Shapiro, J. Bernstein, 1991, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Analogs of tetrahydrofolic acid. XXXIX . selective bromoacylation of polyfunctional molecules for synthesis of active-site-directed irreversible enzyme inhibitors†

D. Santi, J. Jordaan, J. Coward, 1966 .

Hydroxyacetophenone-derived antagonists of the peptidoleukotrienes.

T. Maduskuie, A. K. Willard, P. Bernstein, 1989, Journal of Medicinal Chemistry.

Evolution of a series of peptidoleukotriene antagonists: synthesis and structure/activity relationships of 1,3,5-substituted indoles and indazoles.

R. Keith, V. Matassa, T. Maduskuie, 1990, Journal of medicinal chemistry.

Irreversible enzyme inhibitors. LXXI. Candidate active-site-directed irreversible inhibitors of dihydrofolic reductase. V. Derivatives of 6-phenylpyrimidine.

H. Shapiro, B. R. Baker, 1967, Journal of pharmaceutical sciences.

Analogs of tetrahydrofolic acid 34. Hydrophobic bonding to dihydrofolic reductase VI. Mode of phenyl binding of some 6-arylpyrimidines.

H. Shapiro, B. R. Baker, 1966, Journal of pharmaceutical sciences.

9. Non-Collagenous Bone Proteins and Their Role in Substrate-Induced Bioactivity

J. Wrana, S. Kasugai, H. Goldberg, 1991 .

ANALOGS OF TETRAHYDROFOLIC ACID. XIV. FACILE SYNTHETIC ROUTE TO THE 2-AMINO-5-(3-ANILINOPROPYL)-6-METHYL-4-PYRIMIDINOL TYPE OF FOLIC REDUCTASE AND THYMIDYLATE SYNTHETASE INHIBITOR.

D. Santi, H. Shapiro, B. R. Baker, 1964, Journal of pharmaceutical sciences.

Minimal renal amyloidosis with nephrotic syndrome.

B. Jones, H. Shapiro, J. Bernstein, 1986, Archives of pathology & laboratory medicine.

N-aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropanamides: KATP potassium channel openers. Modifications on the western region.

K. Gibson, B. Masek, J. Empfield, 1996, Journal of medicinal chemistry.

Anilide tertiary carbinols: A new structural class of potent potassium channel openers

K. Russell, H. Shapiro, Jack H. Y. Li, 1993 .

A highly potent series of fluoroalkyl benzoxazine pyridine-N-oxide potassium channel openers

K. Russell, P. Warwick, H. Shapiro, 1993 .

Synthesis and in vitro LTD4 antagonist activity of bicyclic and monocyclic cyclopentylurethane and cyclopentylacetamide N-arylsulfonyl amides.

V. Matassa, T. Maduskuie, R. Krell, 1990, Journal of medicinal chemistry.